Drug Trial Radar · NCT07935135
Study of CMP-002 in Participants With SYNGAP1-Related Disorder
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Jan 2029
Study completion Jan 2029
Sponsor
- Lead sponsor
- CAMP4 Therapeutics CorporationIndustry
- Sponsor type
- Industry
- First posted
- Nov 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of CMP-002 in participants with SYNGAP1-related disorder.
Conditions
- Nervous System Disease
Interventions
CMP-002Drug
CMP-002 is an antisense oligonucleotide that will be administered by IT injection.
Sham-prickOther
The sham-prick procedure involves no injection/puncture or penetration of the dura, but only a skin prick with a needle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability of multiple doses of CMP-002: incidence of adverse events and changes from baseline in clinical laboratory resultsTime frame: Screening to Week 36
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Alemán
Buenos Aires, Argentina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.